Full Text View
Tabular View
No Study Results Posted
Related Studies
RU-486 in the Treatment of Bipolar Depression
This study has suspended participant recruitment.
Study NCT00359125   Information provided by University of British Columbia

First Received on July 28, 2006.   Last Updated on September 24, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Bipolar Depression
Additional conditions recognized in this trial
Bipolar Disorder
Depression
Depressive Disorder
More general conditions related to this trial
Affective Disorders, Psychotic
Behavioral Symptoms
Mental Disorders
Mood Disorders
Interventions listed in this trial
mifepristone (RU-486)
Placebo
Additional drug interventions recognized in this trial
Mifepristone
More general drug interventions related to this trial
Abortifacient Agents
Abortifacient Agents, Steroidal
Contraceptive Agents
Contraceptive Agents, Female
Contraceptives, Oral
Contraceptives, Oral, Synthetic
Contraceptives, Postcoital
Contraceptives, Postcoital, Synthetic
Hormone Antagonists
Hormones, Hormone Substitutes, and Hormone Antagonists
Luteolytic Agents
Menstruation-Inducing Agents
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Therapeutic Uses
Sponsors listed in this trial
University of British Columbia
Western Economic Diversification Canada
Stanley Medical Research Institute


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services